European Archives - Page 18 of 1216 - European Medical Journal

AI Model Improves Survival Prediction in Patients with Fibrotic Lung Disease

A new AI model shows promise in predicting survival in patients with fibrotic lung disease, offering more precise prognosis than standard tests and imaging methods.

Early MRI Predicts Immunotherapy Response in Triple-Negative Breast Cancer

New MRI model predicts early treatment response in TNBC, supporting faster, more tailored clinical decisions.

Maternal Depression Linked to Adolescent Brain Connectivity Changes

Prenatal maternal depression alters brain connectivity patterns in children through adolescence, new large-cohort study reveals.

Canagliflozin Shows Promise for Children with Type 2 Diabetes

Learn how canagliflozin safely improves glycaemic control in children with Type 2 diabetes.

Olympic Combat Sports Boost Flexibility and Lower-Body Strength

The study examined six key outcomes: muscle strength, standing long jump, vertical jump (Sargent test), cardiorespiratory fitness, flexibility (sit-and-reach), and VO₂max.

Jade Williams and Isabel O'Brien, EMJ GOLD

Season 10’s insights, inspiration and ‘aha’ moments

Listen in to the standout moments from EMJ GOLD’s guests this season, uncovering the challenges and opportunities shaping today’s pharmaceutical industry.

Intrathecal Morphine Reduces Pain After Liver Surgery

Discover a study evaluating how intrathecal morphine improves early postoperative pain relief and reduces morphine use after open liver surgery.

Disrupted Sleep Speeds Dementia Progression via M-Pericytes

Discover how sleep fragmentation accelerates cognitive decline via vascular changes and what this means for dementia prevention. Keep reading.

Current trends of methotrexate therapy

Explore the evolving role of methotrexate (MTX) in rheumatoid arthritis (RA) care in this expert-led podcast featuring leading…

Benralizumab Shows Long-Term Remission Promise in Severe Eosinophilic Asthma

Real-world study finds benralizumab leads to long-term clinical remission in up to 39% of patients with severe eosinophilic asthma.